Microfluidic Chip-based Technologies: Emerging Platforms for Cancer Diagnosis
Overview
Affiliations
The development of early and personalized diagnostic protocols is considered the most promising avenue to decrease mortality from cancer and improve outcome. The emerging microfluidic-based analyzing platforms hold high promises to fulfill high-throughput and high-precision screening with reduced equipment cost and low analysis time, as compared to traditional bulky counterparts in bench-top laboratories. This article overviewed the potential applications of microfluidic technologies for detection and monitoring of cancer through nucleic acid and protein biomarker analysis. The implications of the technologies in cancer cytology that can provide functional personalized diagnosis were highlighted. Finally, the future niches for using microfluidic-based systems in tumor screening were briefly discussed.
Nie C, Shaw I, Chen C J Pharm Anal. 2024; 13(12):1429-1451.
PMID: 38223444 PMC: 10785256. DOI: 10.1016/j.jpha.2023.08.009.
Zhang L, Liao W, Chen S, Chen Y, Cheng P, Lu X Front Oncol. 2023; 13:1146477.
PMID: 37077835 PMC: 10106600. DOI: 10.3389/fonc.2023.1146477.
Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine.
Teixeira A, Carneiro A, Piairo P, Xavier M, Ainla A, Lopes C Adv Exp Med Biol. 2022; 1379:553-590.
PMID: 35761007 DOI: 10.1007/978-3-031-04039-9_22.
Microfluidic Platforms to Unravel Mysteries of Alzheimer's Disease: How Far Have We Come?.
Prasanna P, Rathee S, Rahul V, Mandal D, Chandra Goud M, Yadav P Life (Basel). 2021; 11(10).
PMID: 34685393 PMC: 8537508. DOI: 10.3390/life11101022.
Molinski J, Tadimety A, Burklund A, Zhang J Ann Biomed Eng. 2020; 48(10):2377-2399.
PMID: 32816167 PMC: 7785517. DOI: 10.1007/s10439-020-02593-y.